There is strong optimism in north America that an animal vaccine could soon be developed for the deadly strain of E coli bacteria sometimes referred to as hamburger disease.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A US-Canada team has found positive results in research studies where vaccinated cattle showed a 59% reduction of E coli O157:H7 in their manure compared with unvaccinated cattle in a University of Nebraska research facility in tests carried out during the summers of 2002 and 2003.
Ontario-based Bioniche Life Sciences, the project’s commercial partner, says it will now begin planning for Canadian and American regulatory reviews of a commercial vaccine.
